Patenting Physical Forms in the Pharmaceutical Industry Patenting Physical Forms in the Pharmaceutical Industry By Ray Peck|2020-01-12T16:50:09-05:00May 28th, 2019|Formulation Development & Clinical Trial Materials, Latest Publications|
Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise By Ray Peck|2020-01-11T09:42:29-05:00May 28th, 2019|Formulation Development & Clinical Trial Materials|
Clinical Trial Material Manufacturing in an Age of Increasing Regulatory Oversight Clinical Trial Material Manufacturing in an Age of Increasing Regulatory Oversight By Ray Peck|2020-01-11T09:46:29-05:00April 16th, 2019|Formulation Development & Clinical Trial Materials, Generic & Commercial Drug Manufacturing Services|
New Advances in Preclinical Services May Help to Lower the Cost of Drug Development By Ray Peck|2020-01-11T09:49:18-05:00March 29th, 2019|Formulation Development & Clinical Trial Materials|
The Pros and Cons of Closed-Vial Technology in Sterile Vial Filling The Pros and Cons of Closed-Vial Technology in Sterile Vial Filling By Ray Peck|2020-01-11T09:52:33-05:00March 15th, 2019|Formulation Development & Clinical Trial Materials|
Manufacturing of Capsules Requires Formulation Adaptations Manufacturing of Capsules Requires Formulation Adaptations By Ray Peck|2020-01-11T09:55:59-05:00November 9th, 2018|Formulation Development & Clinical Trial Materials|
Preformulation Preformulation By Ray Peck|2020-01-11T10:00:41-05:00June 15th, 2018|Formulation Development & Clinical Trial Materials|
Clinical Trial Material Manufacturing Clinical Trial Material Manufacturing By Ray Peck|2020-01-11T10:01:30-05:00June 6th, 2018|Formulation Development & Clinical Trial Materials|
Ophthalmic Formulation Development Ophthalmic Formulation Development By Ray Peck|2020-01-11T10:06:02-05:00April 18th, 2018|Formulation Development & Clinical Trial Materials, Ophthalmic|
3 Challenging Complexities of Preclinical Toxicology Studies 3 Challenging Complexities of Preclinical Toxicology Studies By Ray Peck|2020-01-11T10:06:40-05:00April 5th, 2018|Formulation Development & Clinical Trial Materials|
